Log in to save to my catalogue

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7375708

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In a double-blind trial, patients with type 1 diabetes and early-to-moderate diabetic kidney disease were randomly assigned to receive allopurinol, which may slow the decline in the glomerular filtration rate, or placebo. There were no clinically meaningful benefits of serum urate reduction on kidney outcomes with allopurinol therapy.

Alternative Titles

Full title

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7375708

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7375708

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1916624

How to access this item